A revocation to this notice was published on 23 November 2022, Notice No. 2022-go4983.

Notice Type
Departmental
Notice Title

COVID-19 Public Health Response (Isolation and Quarantine) Order 2020—COVID-19 Test Requirements for Self-Isolation

Pursuant to clause 15HE of the COVID-19 Public Health Response (Isolation and Quarantine) Order 2020 (“Order”), I, Dr Ashley Bloomfield, Director-General of Health, hereby designate the following method of medical examination and testing for COVID-19 to be required at the specified time:

Day 0/1 Test

A person in isolation or quarantine under Part 1D of the Order must undergo, either:

  1. A RAT with a negative result, undergone on the day of arrival in New Zealand or 1st day (being up to 24 hours) after that person began their period of self-isolation, or
  2. A RAT with a positive result, that is undergone on the day of arrival in New Zealand or 1st day (being up to 24 hours) after that person began their period of self-isolation and a PCR test undertaken as soon as reasonably practicable after receiving the positive result.

Day 5/6 Test

A person in isolation or quarantine under Part 1D of the Order must also undergo, either:

  1. A RAT with a negative result, on the 5th or 6th day (being between 120 hours and 144 hours) after that person began their period of self-isolation with a negative result, or
  2. A RAT with a positive result, that is undergone on the 5th or 6th day (being between 120 hours and 144 hours) after that person began their period of self-isolation and a PCR test undertaken as soon as reasonably practicable after receiving the positive result.

For the purpose of this notice, a RAT is testing for antigens specific to SARS-CoV-2 (rapid antigen testing).

For the purpose of this notice, a PCR test is testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral ribonucleic acid using polymerase chain reaction (PCR).

This notice will come into force at 11.59pm on 27 February 2022.

Dated at Wellington this 25th day of February 2022.

Dr ASHLEY BLOOMFIELD, Director-General of Health.